229 related articles for article (PubMed ID: 36437407)
1. Early CD4
Bai J; Chiba A; Murayama G; Kuga T; Yahagi Y; Tabe Y; Tamura N; Miyake S
Sci Rep; 2022 Nov; 12(1):20376. PubMed ID: 36437407
[TBL] [Abstract][Full Text] [Related]
2. Non-spike and spike-specific memory T cell responses after the third dose of inactivated COVID-19 vaccine.
Huang R; Ying L; Wang J; Xia J; Zhang Y; Mao H; Zhang R; Zang R; Le Z; Shu Q; Xu J
Front Immunol; 2023; 14():1139620. PubMed ID: 37114058
[TBL] [Abstract][Full Text] [Related]
3. Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals.
Galeota E; Bevilacqua V; Gobbini A; Gruarin P; Bombaci M; Pesce E; Favalli A; Lombardi A; Vincenti F; Ongaro J; Fabbris T; Curti S; Martinovic M; Toccafondi M; Lorenzo M; Critelli A; Clemente F; Crosti M; Sarnicola ML; Martinelli M; La Sala L; Espadas A; Donnici L; Borghi MO; De Feo T; De Francesco R; Prati D; Meroni PL; Notarbartolo S; Geginat J; Gori A; Bandera A; Abrignani S; Grifantini R
Clin Immunol; 2024 Apr; 261():110164. PubMed ID: 38417765
[TBL] [Abstract][Full Text] [Related]
4. Antigen-Specific CD4
Sauerwein KMT; Geier CB; Stemberger RF; Akyaman H; Illes P; Fischer MB; Eibl MM; Walter JE; Wolf HM
Front Immunol; 2022; 13():827048. PubMed ID: 35237272
[TBL] [Abstract][Full Text] [Related]
5. The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants.
Chen Y; Chen L; Yin S; Tao Y; Zhu L; Tong X; Mao M; Li M; Wan Y; Ni J; Ji X; Dong X; Li J; Huang R; Shen Y; Shen H; Bao C; Wu C
Emerg Microbes Infect; 2022 Dec; 11(1):1524-1536. PubMed ID: 35608053
[TBL] [Abstract][Full Text] [Related]
6. Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine.
Chen Y; Yin S; Tong X; Tao Y; Ni J; Pan J; Li M; Wan Y; Mao M; Xiong Y; Yan X; Yang Y; Huang R; Wu C; Shen H
Clin Microbiol Infect; 2022 Mar; 28(3):410-418. PubMed ID: 34715346
[TBL] [Abstract][Full Text] [Related]
7. Persistence of spike-specific immune responses in BNT162b2-vaccinated donors and generation of rapid
Mestiri S; Merhi M; Inchakalody VP; Taib N; Smatti MK; Ahmad F; Raza A; Ali FH; Hydrose S; Fernandes Q; Ansari AW; Sahir F; Al-Zaidan L; Jalis M; Ghoul M; Allahverdi N; Al Homsi MU; Uddin S; Jeremijenko AM; Nimir M; Abu-Raddad LJ; Abid FB; Zaqout A; Alfheid SR; Saqr HMH; Omrani AS; Hssain AA; Al Maslamani M; Yassine HM; Dermime S
Front Immunol; 2023; 14():1061255. PubMed ID: 36817441
[TBL] [Abstract][Full Text] [Related]
8. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
Front Immunol; 2022; 13():863554. PubMed ID: 35711445
[TBL] [Abstract][Full Text] [Related]
9. Immune Response to SARS-CoV-2 Vaccine in 2 Men.
Gupta S; Su H; Agrawal S
Int Arch Allergy Immunol; 2022; 183(3):350-359. PubMed ID: 34794147
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 Severity, Cardiological Outcome, and Immunogenicity of mRNA Vaccine on Adult Patients With 22q11.2 DS.
Pulvirenti F; Mortari EP; Putotto C; Terreri S; Fernandez Salinas A; Cinicola BL; Cimini E; Di Napoli G; Sculco E; Milito C; Versacci P; Agrati C; Marino B; Carsetti R; Quinti I
J Allergy Clin Immunol Pract; 2023 Jan; 11(1):292-305.e2. PubMed ID: 36280136
[TBL] [Abstract][Full Text] [Related]
11. A single dose of COVID-19 vaccine induces a strong T cell and B cell response in healthcare professionals recovered from SARS-CoV-2 infection.
Laranjeira P; Rodrigues T; Silva A; Barbosa P; Reis T; Lopes C; Pinho A; Silva S; Silva I; Carvalho A; Pacheco V; Rodrigues F; Araújo L; Antunes I; Paiva A
Clin Exp Med; 2023 Jun; 23(2):529-537. PubMed ID: 35190936
[TBL] [Abstract][Full Text] [Related]
12. Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.
Milo R; Staun-Ram E; Karussis D; Karni A; Hellmann MA; Bar-Haim E; Miller A;
Front Immunol; 2022; 13():868915. PubMed ID: 35432335
[TBL] [Abstract][Full Text] [Related]
13. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.
Sahin U; Muik A; Vogler I; Derhovanessian E; Kranz LM; Vormehr M; Quandt J; Bidmon N; Ulges A; Baum A; Pascal KE; Maurus D; Brachtendorf S; Lörks V; Sikorski J; Koch P; Hilker R; Becker D; Eller AK; Grützner J; Tonigold M; Boesler C; Rosenbaum C; Heesen L; Kühnle MC; Poran A; Dong JZ; Luxemburger U; Kemmer-Brück A; Langer D; Bexon M; Bolte S; Palanche T; Schultz A; Baumann S; Mahiny AJ; Boros G; Reinholz J; Szabó GT; Karikó K; Shi PY; Fontes-Garfias C; Perez JL; Cutler M; Cooper D; Kyratsous CA; Dormitzer PR; Jansen KU; Türeci Ö
Nature; 2021 Jul; 595(7868):572-577. PubMed ID: 34044428
[TBL] [Abstract][Full Text] [Related]
14. NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens.
Hielscher F; Schmidt T; Klemis V; Wilhelm A; Marx S; Abu-Omar A; Ziegler L; Guckelmus C; Urschel R; Sester U; Widera M; Sester M
J Clin Virol; 2022 Dec; 157():105321. PubMed ID: 36279695
[TBL] [Abstract][Full Text] [Related]
15. T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune Deficiencies.
Pulvirenti F; Di Cecca S; Sinibaldi M; Piano Mortari E; Terreri S; Albano C; Guercio M; Sculco E; Milito C; Ferrari S; Locatelli F; Quintarelli C; Carsetti R; Quinti I
Cells; 2022 Jun; 11(12):. PubMed ID: 35741048
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron.
Tarke A; Coelho CH; Zhang Z; Dan JM; Yu ED; Methot N; Bloom NI; Goodwin B; Phillips E; Mallal S; Sidney J; Filaci G; Weiskopf D; da Silva Antunes R; Crotty S; Grifoni A; Sette A
Cell; 2022 Mar; 185(5):847-859.e11. PubMed ID: 35139340
[TBL] [Abstract][Full Text] [Related]
17. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
Front Immunol; 2021; 12():802858. PubMed ID: 35003131
[TBL] [Abstract][Full Text] [Related]
18. The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients.
Fiorino F; Ciabattini A; Sicuranza A; Pastore G; Santoni A; Simoncelli M; Polvere J; Galimberti S; Baratè C; Sammartano V; Montagnani F; Bocchia M; Medaglini D
Front Immunol; 2022; 13():1017863. PubMed ID: 36248803
[TBL] [Abstract][Full Text] [Related]
19. Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccination.
Taus E; Hofmann C; Ibarrondo FJ; Gong LS; Hausner MA; Fulcher JA; Krogstad P; Kitchen SG; Ferbas KG; Tobin NH; Rimoin AW; Aldrovandi GM; Yang OO
Front Immunol; 2023; 14():1100594. PubMed ID: 36860850
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal monitoring of mRNA-vaccine-induced immunity against SARS-CoV-2.
Monzon-Posadas WO; Zorn J; Peters K; Baum M; Proksch H; Schlüter CB; Menting T; Pušnik J; Streeck H
Front Immunol; 2023; 14():1066123. PubMed ID: 36742295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
